Advanced search
Publication Cover
Drug Metabolism Reviews Volume 42, 2010 - Issue 1
Submit an article Journal homepage
333
Views
21
CrossRef citations to date
0
Altmetric
Review Article

Warfarin and UDP-glucuronosyltransferases: writing a new chapter of metabolism

Drew R. JonesDepartment of Biochemistry and Molecular Biology, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA
,
Jeffery H. MoranArkansas Department of Health, Arkansas Public Health Laboratory, Little, Rock, Arkansas, USA
&
Grover P. MillerDepartment of Biochemistry and Molecular Biology, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USACorrespondence[email protected]
Pages 55-61 | Accepted 27 Jul 2009, Published online: 14 Jan 2010

References

  • Barker, W. (1965). The metabolism of 4-C14-warfarin sodium in rat [Thesis]. University of Wisconsin, Madison, Wisconsin, USA.
  • Barker, W., Hermodson, M., Link, K. (1970). The metabolism of 4-C14-Warfarin Sodium by the rat. J Pharmacol Exp Ther 171:307–313.
  • Chan, E., McLachlan, A. J., Rowland, M. (1993). Warfarin metabolities: Stereochemical aspects of protein binding and displacement by Phenylbutazone. Chirality 5:610–615.
  • Eble, J. (1953). Studies on the 4-hydroxycoumarin anticoagulants warfarin and cyclocumarol. [Thesis]. University of Wisconsin, Madison, Wisconsin, USA, pp. 22–30.
  • Gebauer, M. (2007). Synthesis and structure-activity relationships of novel warfarin derivatives. Bioorg Med Chem 15:2414–2420.
  • Guo, Y., Weller, P., Farrell, E., Cheung, P., Fitch, B., Clark, D., et al. (2006). In silico parmacogenetics of warfarin metabolism. Nat Biotechnol. 24:531–536.
  • Hermodson, M. (1968). Biochemical studies on warfarin [Thesis]. University of Wisconsin, Madison, Wisconsin, USA.
  • Hirsh, J., Dalen, J. E., Anderson, D. R., Poller, L., Bussey, H., Ansell, J., et al. (2001). Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest 119:8S–21S.
  • Jansing, R., Chao, E., Kaminsky, L. (1992). Phase II metabolism of warfarin in primary culture of adult rat hepatocyes. Mol Pharmacol 41:209–215.
  • Kaminsky, L., de Morais, S., Faletto, M., Dunbar, D., Goldstein, J., (1993). Correlation of human cytochromeP4502C substrate specificities with primary structure: warfarin as a probe. Mol Pharmacol 43:234–239.
  • Kaminsky, L. S., Zhang, Z. Y. (1997). Human P450 metabolism of warfarin. Pharmacol Ther 73:67–74.
  • Miller, G. P., Jones, D. R., Sullivan, S. Z., Mazur, A., Owen, S. N., Mitchell, N. C., et al. (2009). Assessing cytochrome P450 and UDP-Glucuronosyltransferase contributions to warfarin metabolisms in humans. Chem Res Toxicol. 22(7): 1239–45.
  • Miller, G. P., Lichti, C. F., Zielinska, A. K., Mazur, A., Bratton, S. M., Gallus-Zawada, A., et al. (2008). Identification of hydroxywarfarin binding site in human UDP glucuronosyltransferase 1A10: phenylalanine 90 is crucial for the glucuronidation of 6- and 7-hydroxywarfarin but not 8-hydroxywarfarin. Drug Metab Dispos 36:2211–2218.
  • Ngui, J. S., Chen, Q., Shou, M., Wang, R. W., Stearns, R. A., Baillie, T. A., et al. (2001). In vitro stimulation of warfarin metabolism by quinidine: increases in the formulation of 4’- and 10’-hydroxywarfarin. Drug Metab Dispos 29:877–886.
  • O’Reilly, R. (1969). Interaction of the anticoagulant drug warfarin and its metabolities with human plasma albumin. J Clin Invest 48:193–202.
  • Rettie, A., Korzekwa, K. R., Kunze, K. L., Lawrence, R. F., Eddy, A. C., Aoyama, T., et al. (1992). Hydroxylation of warfarin by human cDNA-expressed cytochrome P-4SO: A role for P-4502 C9 in the etiology of (S)-warfarin-drug interactions. Chem Res Toxicol 5:54–59.
  • Reynolds, K., Valdes, R. J., Hartung, B. R., Linder, M. W. (2007). Individualizing warfarin therapy. Person Med 4:11–31.
  • Ritter, J. K. (2000). Roles of glucuronidation and UDP-glucuronosyltransferases in xenobiotic bioactivation reactions. Chemico Biolog Interact 129:171–193.
  • Steward, D. J., Haining, R. L., Henne, K. R., Davis, G., Rushmore, T. H., Trager, W. F., et al. (1997). Genetic association between sensitivity to warfarin and expression of CYP2C9*3. Pharmacogenetics 7:361–367.
  • Wienkers, L. C., Wurden, C. J., Storch, E., Kunze, K. L., Rettie, A. E., Trager, W. F. (1996). Formation of (R)-8-hydroxywarfarin in human liver microsomes. A new metabolic marker for the (S)-mephenytoin hydroxylase, P4502C19. Drug Metab Dispos 24:610–614.
  • Zhang, Z., Fasco, M. J., Huang, Z., Guengerich, F. P., Kaminsky, L. S. (1995). Human cytochrome P4501A1 and P4501A2: R-warfarin metabolism as a probe. Drug Metab Dispos 23:1339–1345.
  • Zielinska, A., Lichti, C. F., Bratton, S., Mitchell, N. C., Gallus-Zawada, A., Le, V.-H., et al. (2008). Glucurodination of monohydroxylated warfarin metabolites by human liver microsomes and human recombinant UDP-glucuronosyltransferases. J Pharmacol Exp Ther 324:139–148.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.